Our JAMA Oncology study is now featured in the IJGC podcast! Thank you for highlighting our work. Grateful to work with such an amazing team! David Viveros-Carreño Alex Melamed Roni Nitecki Wilke René Pareja J. Alejandro Rauh-Hain, MD, MPH

That feeling when 7+ years of work lands on the front page of NEJM—and one of the people I respect most, Kohei shitara , writes the editorial. Honored to share this moment with you, Kohei. Here’s to a decade of friendship, and curing gastric cancer. #Matterhorn Memorial Sloan Kettering Cancer Center

🚨 New research led by MSK's Dr. Andrew McPherson, Sohrab Shah & team reveals how whole-genome doubling (WGD) helps #ovariancancer tumors adapt and be more resistant to treatment. The study, which was published in nature, found that over 65% of ovarian cancer tumors showed high

A systematic review of placenta accreta spectrum (PAS) guidelines found strong consensus on antenatal management but gaps in cesarean hysterectomy and postnatal care. ja.ma/3Izx8ha Giulia Bonanni, MD

"If Ayrton hadn't died in Imola we would all be racing for second" Michael Schumacher #F1

🎙️ New #IJGCconversations episode! #EditorialFellows Helena Obermair Helena Obermair & Friederike Stroisch dive into highlights from the #JulyIssue. Don’t miss it! 🔗 bit.ly/4nX0dTT Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO

📍Mirador El Picacho, Medellín

🌟 We are thrilled to announce that Dr. Reitan Ribeiro has been selected to receive the 2025 IGCS Award for Outstanding Achievement in Gynecologic Oncology! An internationally recognized surgeon, Dr. Ribeiro developed the uterine transposition technique, a groundbreaking

Got to witness the 🐐 at work today. Two insanely hard robotic resections and he made it look easy! Always thankful to learn from this guy Mario M. Leitao, Jr 🙌🏻 MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center

New in nature: Drs. Ernst Lengyel, JannaHeide, Lengyel Lab & team discovered a first-of-its-kind NNMT inhibitor that reprograms cancer-associated fibroblasts & restores immune response in ovarian cancer, marking a major step toward better therapies. nature.com/articles/s4158…

Proud to share our new nature study: We developed the 1st NNMT inhibitor that reprograms cancer-associated fibroblasts, boosting immune response & stopping tumor growth in ovarian cancer models, especially when paired with immunotherapy. Lengyel Lab nature.com/articles/s4158…

pubmed.ncbi.nlm.nih.gov/40706071/ I just love mentoring students !!! 📢 New in Obstet Gynecol! We report a 15-year series of 2,328 robotic gynecologic cancer surgeries: 🔹 Overall conversion rate: 2.4% 🔹 For endometrial ca (excluding specimen removal): 0.5% 🔹 No link with BMI/age

If you have a favourite photograph, post it here...

jamanetwork.com/journals/jamao… Great to see our paper out in JAMA Oncology re what should be the Breast Cancer risk thresholds at which we offer Risk Reducing Mastectomy RRM is cost-effective for women with a lifetime BC risk >=35%.

Genomics of host–microbiome interactions in humans | Nature Reviews Genetics nature.com/articles/s4157…

🏃‍♀️I’m running the 2025 NYC Marathon with Fred's Team to support cancer research at Memorial Sloan Kettering Cancer Center. This mission is deeply meaningful—to honor my parents, support my patients, and give back to the place that shaped me. 💙 🔗secure2.convio.net/mskcc/site/TR/…

🎉 Big congrats to Dr. McPherson and Dr. Sohrab Shah’s team on their new Nature paper! Their work on whole-genome doubling in HGSOC offers key insights into disease evolution and treatment. Proud to have them as Team Ovary collaborators! 📖 nature.com/articles/s4158…

I will tell my kids these were Pogacar and Vingegaard attacking at 30 km/h on Mont Ventoux. 💥 One of my highlights of this Tour de France. #TDF2025

🎉 We have some wonderful news to share! MSK is ranked #2 in the nation for cancer care and #1 for urology care according to the U.S. News & World Report 2025-2026 Best Hospitals list. Learn more: bit.ly/41hiXn8

We have over 300 patients on! Nearing our first planned interim analysis!! So important to get this trial done. Thank you to all who are enrolling but mostly THANK YOU to patients who are agreeing to participate!